Charcoal-Based Treatment Can Protect Gut Microbiome from Antibiotics
Ingestible pellets containing a charcoal-like treatment -- designed by the French company Da Volterra --…
The potential of the microbiome to be used for the development of promising therapeutics and diagnostic approaches has spurred a hype around this emerging field. Over the last decade, researchers have found correlations between the human microbiome and a number of diseases, including inflammatory bowel disease, diabetes, autoimmune diseases, cancer, depression, and many more. As the number of clinical trials grows, investor interest is increasing.
Read on to find out more about the flourishing microbiome field and how it shows promise for the treatment of a large variety of diseases.
Beyond the Gut: An Atlas of the Human Microbiome
This report discusses the role of the gut and blood microbiomes in different diseases and how they can be used for biomarker discovery and for the development of therapeutics.
Go to ReportIngestible pellets containing a charcoal-like treatment -- designed by the French company Da Volterra --…
French company MaaT Pharma has raised €18M in Series B financing that will support phase…
Gedea Biotech is nestled in the historic city of Lund, Sweden. The company is developing…
With the year coming to a close, it’s time to review the most important biotech…
Merck will pay the microbiome company 4D Pharma up to €316.5M to develop vaccines based…
A food supplement made from bacteria, developed by a Belgian research group, has improved symptoms…
The death of a US patient from complications after a fecal transplant last week could…
European biotech companies gathered in Chicago, USA, to share the latest advances in cancer research…
European microbiome biotechs have launched a collaboration to streamline the EU’s regulatory pathways for microbiome-based…
Over the last decade, the biotech industry has built a lot of hype around the…
Biotech investors regularly jump on new crazes, including the microbiome and CRISPR-Cas9 gene editing. At…
We’re zooming over to France this week. The biotech Kapsera makes capsules of microbes that…